<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Screening <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is controversial owing to a large variation in the reported incidence of neoplastic change and lack of evidence that screening improves <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To determine the incidence of Barrett's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, its cost of detection, and stage of disease at time of diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: Data from our surveillance programme have been reviewed to assess the incidence of malignant change, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> stage at diagnosis, and the cost per <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> detected </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: 166 patients had annual endoscopic surveillance </plain></SENT>
<SENT sid="4" pm="."><plain>Six patients (five men) developed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-an incidence of one <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> per 59 male and 167 female patient-years of follow up </plain></SENT>
<SENT sid="5" pm="."><plain>The screened group had a significantly earlier stage than a control group of unscreened <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The cost of detecting one <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was Pounds 14 868 for men and Pounds 42 084 for women </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The cost of screening for Barrett's <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is high but may be justified on the basis of the high incidence of detecting early stage disease </plain></SENT>
</text></document>